Physician profile

Robert Michael Lee

General Practice (Dentist) · Baton Rouge, LA

NPI 1649496555

$275.99

in general payments reported to CMS, 2019-2025

6 companies · none reported in 2025

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$61.51

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Ultradent Products INC $125.37 2022-2024
Septodont INC. $72.93 2020
Voco America INC. $32.79 2019-2024 Grandio So Heavy Flow, Admira Fusion X-Tra, Voco Profluorid Varnish
Kerr Corporation $16.47 2021
Solventum Corporation $14.34 2024 3m Relyx, 3m Espe Filtek Supreme Ultra Universal Restorative, 3m Scotchbond
3m Company $14.09 2023 3m Filtek, 3m Espe Filtek Supreme Ultra Universal Restorative, 3m Relyx

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Robert Michael Lee

$275.99

in general payments reported 2019-2025

Years
2019-2024
Top company
Ultradent Products INC

https://glasscript.com/doctor/552516/robert-michael-lee

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.